These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27238847)

  • 1. Clinical characterization and long-term follow-up of Schnitzler syndrome.
    Gameiro A; Gouveia M; Pereira M; Tellechea O; Gonçalo M
    Clin Exp Dermatol; 2016 Jul; 41(5):461-7. PubMed ID: 27238847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment.
    de Koning HD; Bodar EJ; van der Meer JW; Simon A;
    Semin Arthritis Rheum; 2007 Dec; 37(3):137-48. PubMed ID: 17586002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome.
    Matsuda T; Takimoto-Ito R; Lipsker D; Kambe N
    Allergol Int; 2023 Jul; 72(3):385-393. PubMed ID: 36906447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophilic epitheliotropism, proposed as an auto-inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases.
    Nakaizumi H; Kambe N; Irie H; Kaku Y; Fujimoto M; Yoshifuji H; Kazuma Y; Katagiri K; Kanekura T; Kabashima K
    J Dermatol; 2024 Apr; 51(4):592-596. PubMed ID: 38057948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transformation of IgM-MGUS into Waldenström´s macroglobulinemia in two of six patients treated for Schnitzler´s syndrome].
    Adam Z; Tomíška M; Řehák Z; Koukalová R; Krejčí M; Král Z; Adamová Z; Ševčíková S; Pour L; Štork M; Krejčí M; Sandecká V
    Vnitr Lek; 2021; 67(E-3):15-23. PubMed ID: 34171947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schnitzler's syndrome: report of a case with progression to Waldenström's macroglobulinaemia.
    Welsh B; Tate B
    Australas J Dermatol; 1999 Nov; 40(4):201-3. PubMed ID: 10570556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schnitzler syndrome associated with systemic marginal zone B-cell lymphoma.
    Dalle S; Balme B; Sebban C; Pariset C; Berger F; Thomas L
    Br J Dermatol; 2006 Oct; 155(4):827-9. PubMed ID: 16965436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Chinese case series of Schnitzler syndrome and complete remission in one tocilizumab-treated patient.
    Yan R; Cao W; Liu X; Li F; Shen M
    Clin Rheumatol; 2020 Dec; 39(12):3847-3852. PubMed ID: 32519052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Schnitzler syndrome: chronic urticaria in disguise: a single-centre report of 11 cases and a critical reappraisal of the literature.
    Vanderschueren S; van der Veen A
    Clin Exp Rheumatol; 2017; 35(1):69-73. PubMed ID: 27606610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan.
    Takimoto-Ito R; Kambe N; Kogame T; Nomura T; Izawa K; Jo T; Kazuma Y; Yoshifuji H; Tabuchi Y; Abe H; Yamamoto M; Nakajima K; Tomita O; Yagi Y; Katagiri K; Matsuzaka Y; Takeuchi Y; Hatanaka M; Kanekura T; Takeuchi S; Kadono T; Fujita Y; Migita K; Fujino T; Akagi T; Mukai T; Nagano T; Kawano M; Kimura H; Okubo Y; Morita A; Hide M; Satoh T; Asahina A; Kanazawa N; Kabashima K
    Allergol Int; 2023 Apr; 72(2):297-305. PubMed ID: 36470790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study.
    Krause K; Weller K; Stefaniak R; Wittkowski H; Altrichter S; Siebenhaar F; Zuberbier T; Maurer M
    Allergy; 2012 Jul; 67(7):943-50. PubMed ID: 22583335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Schnitzler's syndrome without monoclonal gammopathy successfully treated with canakinumab.
    Fujita Y; Asano T; Sakai A; Norikawa N; Yamamoto T; Matsumoto H; Sato S; Temmoku J; Yashiro-Furuya M; Matsuoka N; Watanabe H; Migita K
    BMC Musculoskelet Disord; 2021 Mar; 22(1):257. PubMed ID: 33685423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study.
    Néel A; Henry B; Barbarot S; Masseau A; Perrin F; Bernier C; Kyndt X; Puechal X; Weiller PJ; Decaux O; Ninet J; Hot A; Aouba A; Astudillo L; Berthelot JM; Bonnet F; Brisseau JM; Cador B; Closs-Prophette F; Dejoie T; de Korwin JD; Dhote R; Fior R; Grosbois B; Hachulla E; Hatron PY; Jardel H; Launay D; Lorleac'h A; Pottier P; Moulis G; Serratrice J; Smail A; Hamidou M
    Autoimmun Rev; 2014 Oct; 13(10):1035-41. PubMed ID: 25220180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Schnitzler syndrome. Four new cases and review of the literature.
    Lipsker D; Veran Y; Grunenberger F; Cribier B; Heid E; Grosshans E
    Medicine (Baltimore); 2001 Jan; 80(1):37-44. PubMed ID: 11204501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant evolution of Schnitzler's syndrome--chronic urticaria and IgM monoclonal gammopathy: report of a new case and review of the literature.
    Lim W; Shumak KH; Reis M; Perez-Ordonez B; Sauder D; Fam A; Imrie KR
    Leuk Lymphoma; 2002 Jan; 43(1):181-6. PubMed ID: 11908725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CCL2 with systemic inflammation in Schnitzler syndrome.
    Krause K; Sabat R; Witte-Händel E; Schulze A; Puhl V; Maurer M; Wolk K
    Br J Dermatol; 2019 Apr; 180(4):859-868. PubMed ID: 30339714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schnitzler's Syndrome-Diagnostic Experience, Approaches to Therapy, and Patient Management according to a Multicenter Russian Cohort.
    Salugina SO; Torgashina AV; Borzova EY; Rameev VV; Gorodetsky VR; Fedorov ES; Muravyova NV
    Dokl Biochem Biophys; 2024 Aug; 517(1):214-227. PubMed ID: 38861148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.
    Huang Y; Wang Y; Yu F; Mao X; Wang B; Li J; Li L
    Front Immunol; 2022; 13():894464. PubMed ID: 35514998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab.
    Salcedo-Mingoarranz AL; Dorado-Fernández M; García-Martínez S; Collado-Ramos P; Silvestre-Torner N
    J Dermatolog Treat; 2023 Dec; 34(1):2242705. PubMed ID: 37551725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review.
    Bixio R; Rossini M; Giollo A
    Clin Rheumatol; 2021 Jul; 40(7):2973-2977. PubMed ID: 33175311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.